| HOME >> BIOLOGY >> TECHNOLOGY |
MENLO PARK, Calif., April 7, 2008 /PRNewswire/ -- InterWest Partners announced today the appointment of three internationally renowned scientists to the venture capital firm's Advisory Committee: Caltech president Dr. Jean-Lou Chameau, biotechnology pioneer Dr. Leroy Hood, and former FDA commissioner Dr. Mark McClellan. The three will join InterWest's roster of experienced professional advisors, providing strategic guidance to the firm and its portfolio companies.
"Drs. Chameau, Hood and McClellan each bring a wealth of experience and knowledge to our business and will be instrumental in the continued development of our portfolio as well as the innovators we serve," said Dr. Arnold L. Oronsky, general partner at InterWest. "We are excited to welcome these three luminaries to the InterWest team."
Dr. Jean-Lou Chameau leads one of the world's preeminent centers of instruction and research in engineering and science, the California Institute of Technology (Caltech). Prior to becoming president of Caltech, Dr. Chameau served as professor, research scholar and provost of Georgia Tech in Atlanta; he also served as dean of Georgia Tech's College of Engineering, the largest engineering school in the country. His undergraduate education took place in France and he received his graduate degree in civil engineering from Stanford University. He is the former president of Golder Associates, an international geotechnical consulting company, and currently serves on the boards of directors for MTS Systems Corporation, the Academic Research Council of Singapore, the Council on Competitiveness, and l'Ecole Polytechnique. Dr. Chameau was the recipient of a National Science Foundation Presidential Young Investigator Award, the ASCE Arthur Casagrande Award, the Rodney Chipp Memorial Award from the Society of Women Engineers, and the Prix Nessim Habif from the Ecole Nationale Superieure des Arts-et-Metiers.
Leroy Hood, M.D., Ph.D., has been a member of the Int
'/>"/>
| SOURCE InterWest Partners Copyright©2008 PR Newswire. All rights reserved |